Silo Pharma (SILO) Insider Trading & Ownership $0.58 -0.04 (-7.13%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$0.60 +0.02 (+3.31%) As of 07/11/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Silo Pharma (NASDAQ:SILO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.37%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$11.03KNumber OfInsiders Selling(Last 12 Months)0 Get SILO Insider Trade Alerts Want to know when executives and insiders are buying or selling Silo Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SILO Insider Buying and Selling by Quarter Silo Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/27/2025Eric WeisblumCEOBuy10,000$0.43$4,300.00 12/13/2024Eric WeisblumCEOBuy2,500$0.84$2,100.00 11/22/2024Eric WeisblumCEOBuy2,500$0.90$2,250.00 11/20/2024Eric WeisblumCEOBuy2,500$0.95$2,375.00 (Data available from 1/1/2013 forward) SILO Insider Trading Activity - Frequently Asked Questions Who is on Silo Pharma's Insider Roster? The list of insiders at Silo Pharma includes Daniel E Ryweck, and Eric Weisblum. Learn more on insiders at SILO. What percentage of Silo Pharma stock is owned by insiders? 4.37% of Silo Pharma stock is owned by insiders. Learn more on SILO's insider holdings. Which Silo Pharma insiders have been buying company stock? The following insider purchased SILO shares in the last 24 months: Eric Weisblum ($28,020.12). How much insider buying is happening at Silo Pharma? Insiders have purchased a total of 27,544 SILO shares in the last 24 months for a total of $28,020.12 bought. Silo Pharma Key ExecutivesMr. Eric Weisblum (Age 54)Chairman, President & CEO Compensation: $569.01k1 recent tradesMr. Daniel E. Ryweck (Age 59)Chief Financial Officer Compensation: $62.69kDr. James S. Kuo M.B.A. (Age 59)M.D., Vice President of Research & Development More Insider Trading Tools from MarketBeat Related Companies Perfect Moment Insider Buying lululemon athletica Insider Buying Levi Strauss & Co. Insider Buying The Baldwin Insurance Group Insider Buying Kontoor Brands Insider Buying Under Armour Insider Buying Under Armour Insider Buying Capri Insider Buying FIGS Insider Buying J.Jill Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Do They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold? This page (NASDAQ:SILO) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.